FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2800930282> ?p ?o ?g. }

• W2800930282 endingPage "e0195822" @default.
• W2800930282 startingPage "e0195822" @default.
• W2800930282 abstract "Background Respiratory viruses such as respiratory syncytial virus (RSV) or rhinovirus are one of the major causes for respiratory tract infections causing common cold disease. Respiratory viral infections range from mild symptoms in adults to serious illness especially in the very young or elderly as well as patients suffering from lung diseases or being immunocompromised due to other reasons. Engystol (EGY-2) is a multicomponent, multitarget preparation consisting of Vincetoxicum hirundinaria and Sulfur in various dilutions. The study objective was to test the effect of EGY-2 on the innate immune response during the early onset of respiratory viral infection in vivo as exemplified in a mouse model of RSV-induced respiratory inflammation. Methods Naïve BALB/c mice were infected with 1x106 infectious units RSV A2 intranasally to cause a mild respiratory infection. EGY-2 was administered daily per oral gavage starting seven days prior to RSV infection at doses of 0.4 to 5.1 tablets/kg. Control groups received placebo treatment. Animals were sacrificed 1 to 3 days post infection (p.i.) to analyse the infection and induced immune response in the lung. Viral load in bronchoalveolar lavage fluid (BALF) and lung homogenate was determined by TCID50 assay as well as immunofluorescence staining of BALF cells using anti-RSV antibody and microscopic analysis. The RSV induced immune response was assessed by evaluation of BALF differential cell count, BALF cytokine secretion and analysis of the phagocytic capacity of alveolar macrophages. Results EGY-2 significantly reduced the RSV induced neutrophil and early lymphocyte influx on day 1 p.i. in BALF. EGY-2 treatment significantly diminished the RSV induced secretion of pro-inflammatory cytokines such as IFN-γ, IL-1β, IL-6, KC and TNF-α at day 1. EGY-2 treatment was not protective for RSV infection per se, as no alteration in the viral load in lung and BALF was detected. Enhanced numbers of phagocytic-active macrophages were observed in EGY-2 treated animals on day 1 and this macrophage population showed strongly enhanced phagocytic activity on day 1 and day 3. Conclusion The data suggest a beneficial immunomodulatory effect of EGY-2 during early onset of respiratory viral infection in vivo, mediated by stimulation of macrophage phagocytosis, resulting in a reduced innate inflammatory response in terms of neutrophil and early lymphocyte infiltration as well as reduced inflammatory cytokine secretion." @default.
• W2800930282 created "2018-05-17" @default.
• W2800930282 creator A5016130556 @default.
• W2800930282 creator A5025548416 @default.
• W2800930282 creator A5031071186 @default.
• W2800930282 creator A5032072911 @default.
• W2800930282 creator A5034420912 @default.
• W2800930282 creator A5056334636 @default.
• W2800930282 creator A5056688753 @default.
• W2800930282 creator A5070071459 @default.
• W2800930282 date "2018-04-19" @default.
• W2800930282 modified "2023-09-29" @default.
• W2800930282 title "Engystol reduces onset of experimental respiratory syncytial virus-induced respiratory inflammation in mice by modulating macrophage phagocytic capacity" @default.
• W2800930282 cites W1489136175 @default.
• W2800930282 cites W1493418008 @default.
• W2800930282 cites W1970866975 @default.
• W2800930282 cites W1986231627 @default.
• W2800930282 cites W1995959331 @default.
• W2800930282 cites W2004220996 @default.
• W2800930282 cites W2004255810 @default.
• W2800930282 cites W2015916493 @default.
• W2800930282 cites W2027079842 @default.
• W2800930282 cites W2029494678 @default.
• W2800930282 cites W2036839244 @default.
• W2800930282 cites W2044757050 @default.
• W2800930282 cites W2062634223 @default.
• W2800930282 cites W2088741862 @default.
• W2800930282 cites W2103728319 @default.
• W2800930282 cites W2110812524 @default.
• W2800930282 cites W2124410341 @default.
• W2800930282 cites W2139392338 @default.
• W2800930282 cites W2147480427 @default.
• W2800930282 cites W2153771979 @default.
• W2800930282 cites W2157380267 @default.
• W2800930282 cites W2177938143 @default.
• W2800930282 cites W2345044317 @default.
• W2800930282 cites W2472015174 @default.
• W2800930282 cites W2792129334 @default.
• W2800930282 doi "https://doi.org/10.1371/journal.pone.0195822" @default.
• W2800930282 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5909611" @default.
• W2800930282 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29672626" @default.
• W2800930282 hasPublicationYear "2018" @default.
• W2800930282 type Work @default.
• W2800930282 sameAs 2800930282 @default.
• W2800930282 citedByCount "6" @default.
• W2800930282 countsByYear W28009302822019 @default.
• W2800930282 countsByYear W28009302822020 @default.
• W2800930282 countsByYear W28009302822021 @default.
• W2800930282 countsByYear W28009302822023 @default.
• W2800930282 crossrefType "journal-article" @default.
• W2800930282 hasAuthorship W2800930282A5016130556 @default.
• W2800930282 hasAuthorship W2800930282A5025548416 @default.
• W2800930282 hasAuthorship W2800930282A5031071186 @default.
• W2800930282 hasAuthorship W2800930282A5032072911 @default.
• W2800930282 hasAuthorship W2800930282A5034420912 @default.
• W2800930282 hasAuthorship W2800930282A5056334636 @default.
• W2800930282 hasAuthorship W2800930282A5056688753 @default.
• W2800930282 hasAuthorship W2800930282A5070071459 @default.
• W2800930282 hasBestOaLocation W28009302821 @default.
• W2800930282 hasConcept C126322002 @default.
• W2800930282 hasConcept C142462285 @default.
• W2800930282 hasConcept C203014093 @default.
• W2800930282 hasConcept C2522874641 @default.
• W2800930282 hasConcept C2776012195 @default.
• W2800930282 hasConcept C2776914184 @default.
• W2800930282 hasConcept C2777714996 @default.
• W2800930282 hasConcept C2777961210 @default.
• W2800930282 hasConcept C2779278377 @default.
• W2800930282 hasConcept C2779644171 @default.
• W2800930282 hasConcept C534529494 @default.
• W2800930282 hasConcept C71924100 @default.
• W2800930282 hasConcept C8891405 @default.
• W2800930282 hasConceptScore W2800930282C126322002 @default.
• W2800930282 hasConceptScore W2800930282C142462285 @default.
• W2800930282 hasConceptScore W2800930282C203014093 @default.
• W2800930282 hasConceptScore W2800930282C2522874641 @default.
• W2800930282 hasConceptScore W2800930282C2776012195 @default.
• W2800930282 hasConceptScore W2800930282C2776914184 @default.
• W2800930282 hasConceptScore W2800930282C2777714996 @default.
• W2800930282 hasConceptScore W2800930282C2777961210 @default.
• W2800930282 hasConceptScore W2800930282C2779278377 @default.
• W2800930282 hasConceptScore W2800930282C2779644171 @default.
• W2800930282 hasConceptScore W2800930282C534529494 @default.
• W2800930282 hasConceptScore W2800930282C71924100 @default.
• W2800930282 hasConceptScore W2800930282C8891405 @default.
• W2800930282 hasIssue "4" @default.
• W2800930282 hasLocation W28009302821 @default.
• W2800930282 hasLocation W28009302822 @default.
• W2800930282 hasLocation W28009302823 @default.
• W2800930282 hasLocation W28009302824 @default.
• W2800930282 hasLocation W28009302825 @default.
• W2800930282 hasOpenAccess W2800930282 @default.
• W2800930282 hasPrimaryLocation W28009302821 @default.
• W2800930282 hasRelatedWork W1999401278 @default.
• W2800930282 hasRelatedWork W2021361702 @default.
• W2800930282 hasRelatedWork W2051151508 @default.
• W2800930282 hasRelatedWork W2079049520 @default.
• W2800930282 hasRelatedWork W2138116758 @default.

• next